Last update 21 Nov 2024
XTR-004
Last update 21 Nov 2024
Overview
Basic Info
Drug Type Small molecule drug |
Synonyms |
Target- |
Mechanism- |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 2 |
First Approval Date- |
Regulation- |
Login to view timeline
Related
4
Clinical Trials associated with XTR-004Evaluation of XTR004 as a Novel 18F-labeled PET Myocardial Perfusion Imaging (MPI) Tracer in Diagnosis of Known or Suspected CAD Compared With Invasive Coronary Angiography, Fractional Flow Reserve, Index of Microcirculatory Resistance
评估新型18F标记心肌灌注PET显像剂XTR004注射液对于可疑或已知稳定性冠心病诊断及冠脉功能异常检测效能的临床研究
[Translation] A clinical study to evaluate the efficacy of the new 18F-labeled myocardial perfusion PET imaging agent XTR004 injection in the diagnosis of suspected or known stable coronary heart disease and detection of coronary artery dysfunction
评估新型18F-标记心肌灌注 PET 显像剂 XTR004 注射液在健康成年人中的安全性、生物分布、辐射剂量及药代动力学单中心、开放、非随机、单臂 I 期临床研究
[Translation] A single-center, open-label, non-randomized, single-arm Phase I clinical study to evaluate the safety, biodistribution, radiation dose and pharmacokinetics of the novel 18F-labeled myocardial perfusion PET imaging agent XTR004 injection in healthy adults
100 Clinical Results associated with XTR-004
Login to view more data
100 Translational Medicine associated with XTR-004
Login to view more data
100 Patents (Medical) associated with XTR-004
Login to view more data
1
Literatures (Medical) associated with XTR-00401 Apr 2024Journal of Nuclear Cardiology
Phase I, first-in-human study of XTR004, a novel 18F-labeled tracer for myocardial perfusion PET: Biodistribution, radiation dosimetry, pharmacokinetics, and safety after a single injection at rest
Article
Author: Pan, Qingqing ; Ren, Chao ; Fu, Chao ; Wang, Peipei ; Hsu, Bailing ; Huo, Li ; Zheng, Zhiquan
100 Deals associated with XTR-004
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Coronary Artery Disease | Phase 2 | CN | 18 Jan 2022 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free